Opposing effects of mitogenic and nonmitogenic lectins on lymphocyte activation. Evidence that wheat germ agglutinin produces a negative signal. 1976

W C Greene, and C M Parker, and C W Parker

In an effort to clarify the mechanism by which certain plant lectins induce lymphocyte activation, we have studied amino acid (amino[14C]isobutyric acid) uptake in purified human lymphocytes exposed to mitogenic and nonmitogenic lectins. In confirmation of earlier work, mitogenic lectins (concanavalin A and two phytohemagglutinins) produced a dose-related, 2- to 10-fold increase in aminoisobutyric acid transport. Changes occurred as early as 2 hours and reached a maximum after 18 hours. The stimulation by concanavalin A was inhibited by alpha-methyl-D-mannoside but not by other selected monosaccharides, indicating that the effect is modulated through specific carbohydrate receptors. In contrast to the stimulation with concanavalin A and phytohemagglutinin, the nonmitogen wheat germ agglutinin inhibited aminoisobutyric acid transport, both in the presence and absence of the mitogenic lectins. The inhibition was seen over a broad wheat germ agglutinin dose range, was prevented by N-acetylglucosamine, a known inhibitor of wheat germ agglutinin binding, and did not appear to be associated with cytotoxicity. Comparative binding studies with radiolabeled concanavalin A and wheat germ agglutinin demonstrated that differences in transport occurred in cells containing comparable numbers of bound lectin molecules indicating that the failure of wheat germ agglutinin to stimulate a response was not a result of ineffective binding. The lack of stimulation by wheat germ agglutinin was not due to its inability to interact multivalently with membrane receptors since this lectin is divalent, produces capping and agglutination, and continues to inhibit aminoisobutyric acid transport even after the minimum valence was increased to 4 by cross-linking with glutaraldehyde. In contrast both divalent and tetravalent concanavalin A produced stimulation. Competitive binding studies with soluble wheat germ agglutinin or lectin attached to 300 A latex spheres revealed little or no competition for binding sites with radiolabeled concanavalin A, suggesting the two lectins are interacting with different receptors. This was further suggested by kinetic studies of aminoisobutyric acid transport which indicated that wheat germ agglutinin was probably affecting both the Vmax and Km of transport, whereas concanavalin A affected only the Vmax. While the mechanism by which concanavalin A and wheat germ agglutinin produce opposing effects on amino acid transport is not clear, since the two lectins appear to be interacting with different surface receptors we would suggest that they are perturbing microanatomically and functionally different domains on the lymphocyte plasma membrane.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000621 Aminoisobutyric Acids A group of compounds that are derivatives of the amino acid 2-amino-2-methylpropanoic acid. Acids, Aminoisobutyric
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

W C Greene, and C M Parker, and C W Parker
April 1987, Scandinavian journal of immunology,
W C Greene, and C M Parker, and C W Parker
June 1980, Journal of immunology (Baltimore, Md. : 1950),
W C Greene, and C M Parker, and C W Parker
January 1988, Microbiology and immunology,
W C Greene, and C M Parker, and C W Parker
July 1993, The British journal of nutrition,
W C Greene, and C M Parker, and C W Parker
May 1974, Nature,
W C Greene, and C M Parker, and C W Parker
January 1983, Progress in clinical and biological research,
W C Greene, and C M Parker, and C W Parker
January 1985, Journal of immunology (Baltimore, Md. : 1950),
W C Greene, and C M Parker, and C W Parker
February 1980, FEBS letters,
W C Greene, and C M Parker, and C W Parker
October 1976, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!